Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Botulinum toxin is unsatisfactory therapy for fibromyalgia

Identifieur interne : 003378 ( PascalFrancis/Corpus ); précédent : 003377; suivant : 003379

Botulinum toxin is unsatisfactory therapy for fibromyalgia

Auteurs : G. W. Paulson ; W. Gill

Source :

RBID : Pascal:96-0334229

Descripteurs français

English descriptors


Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0885-3185
A03   1    @0 Mov. disord.
A05       @2 11
A06       @2 4
A08 01  1  ENG  @1 Botulinum toxin is unsatisfactory therapy for fibromyalgia
A11 01  1    @1 PAULSON (G. W.)
A11 02  1    @1 GILL (W.)
A14 01      @1 Department of Neurology, Ohio State University @2 Columbus, Ohio @3 USA @Z 1 aut. @Z 2 aut.
A20       @2 p. 459
A21       @1 1996
A23 01      @0 ENG
A43 01      @1 INIST @2 20953 @5 354000060104000230
A44       @0 0000 @1 © 1996 INIST-CNRS. All rights reserved.
A45       @0 2 ref.
A47 01  1    @0 96-0334229
A60       @1 P
A61       @0 A
A64 01  1    @0 Movement disorders
A66 01      @0 USA
C02 01  X    @0 002B02B11
C03 01  X  FRE  @0 Fibromyalgie @5 01
C03 01  X  ENG  @0 Fibromyalgia @5 01
C03 01  X  SPA  @0 Fibromialgia @5 01
C03 02  X  FRE  @0 Toxine @5 04
C03 02  X  ENG  @0 Toxin @5 04
C03 02  X  SPA  @0 Toxina @5 04
C03 03  X  FRE  @0 Botulisme @5 05
C03 03  X  ENG  @0 Botulism @5 05
C03 03  X  SPA  @0 Botulismo @5 05
C03 04  X  FRE  @0 Chimiothérapie @5 06
C03 04  X  ENG  @0 Chemotherapy @5 06
C03 04  X  SPA  @0 Quimioterapia @5 06
C03 05  X  FRE  @0 Efficacité traitement @5 07
C03 05  X  ENG  @0 Treatment efficiency @5 07
C03 05  X  SPA  @0 Eficacia tratamiento @5 07
C03 06  X  FRE  @0 Traitement @5 17
C03 06  X  ENG  @0 Treatment @5 17
C03 06  X  GER  @0 Aufbereiten @5 17
C03 06  X  SPA  @0 Tratamiento @5 17
C03 07  X  FRE  @0 Homme @5 20
C03 07  X  ENG  @0 Human @5 20
C03 07  X  SPA  @0 Hombre @5 20
C03 08  X  FRE  @0 Douleur @5 25
C03 08  X  ENG  @0 Pain @5 25
C03 08  X  SPA  @0 Dolor @5 25
C07 01  X  FRE  @0 Bactériose
C07 01  X  ENG  @0 Bacteriosis
C07 01  X  SPA  @0 Bacteriosis
C07 02  X  FRE  @0 Infection
C07 02  X  ENG  @0 Infection
C07 02  X  SPA  @0 Infección
C07 03  X  FRE  @0 Système ostéoarticulaire pathologie @5 37
C07 03  X  ENG  @0 Diseases of the osteoarticular system @5 37
C07 03  X  SPA  @0 Sistema osteoarticular patología @5 37
C07 04  X  FRE  @0 Muscle strié pathologie @5 38
C07 04  X  ENG  @0 Striated muscle disease @5 38
C07 04  X  SPA  @0 Músculo estriado patología @5 38
N21       @1 232

Format Inist (serveur)

NO : PASCAL 96-0334229 INIST
ET : Botulinum toxin is unsatisfactory therapy for fibromyalgia
AU : PAULSON (G. W.); GILL (W.)
AF : Department of Neurology, Ohio State University/Columbus, Ohio/Etats-Unis (1 aut., 2 aut.)
DT : Publication en série; Niveau analytique
SO : Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 1996; Vol. 11; No. 4; p. 459; Bibl. 2 ref.
LA : Anglais
CC : 002B02B11
FD : Fibromyalgie; Toxine; Botulisme; Chimiothérapie; Efficacité traitement; Traitement; Homme; Douleur
FG : Bactériose; Infection; Système ostéoarticulaire pathologie; Muscle strié pathologie
ED : Fibromyalgia; Toxin; Botulism; Chemotherapy; Treatment efficiency; Treatment; Human; Pain
EG : Bacteriosis; Infection; Diseases of the osteoarticular system; Striated muscle disease
GD : Aufbereiten
SD : Fibromialgia; Toxina; Botulismo; Quimioterapia; Eficacia tratamiento; Tratamiento; Hombre; Dolor
LO : INIST-20953.354000060104000230
ID : 96-0334229

Links to Exploration step

Pascal:96-0334229

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Botulinum toxin is unsatisfactory therapy for fibromyalgia</title>
<author>
<name sortKey="Paulson, G W" sort="Paulson, G W" uniqKey="Paulson G" first="G. W." last="Paulson">G. W. Paulson</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neurology, Ohio State University</s1>
<s2>Columbus, Ohio</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Gill, W" sort="Gill, W" uniqKey="Gill W" first="W." last="Gill">W. Gill</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neurology, Ohio State University</s1>
<s2>Columbus, Ohio</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">96-0334229</idno>
<date when="1996">1996</date>
<idno type="stanalyst">PASCAL 96-0334229 INIST</idno>
<idno type="RBID">Pascal:96-0334229</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">003378</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Botulinum toxin is unsatisfactory therapy for fibromyalgia</title>
<author>
<name sortKey="Paulson, G W" sort="Paulson, G W" uniqKey="Paulson G" first="G. W." last="Paulson">G. W. Paulson</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neurology, Ohio State University</s1>
<s2>Columbus, Ohio</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Gill, W" sort="Gill, W" uniqKey="Gill W" first="W." last="Gill">W. Gill</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neurology, Ohio State University</s1>
<s2>Columbus, Ohio</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint>
<date when="1996">1996</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Botulism</term>
<term>Chemotherapy</term>
<term>Fibromyalgia</term>
<term>Human</term>
<term>Pain</term>
<term>Toxin</term>
<term>Treatment</term>
<term>Treatment efficiency</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Fibromyalgie</term>
<term>Toxine</term>
<term>Botulisme</term>
<term>Chimiothérapie</term>
<term>Efficacité traitement</term>
<term>Traitement</term>
<term>Homme</term>
<term>Douleur</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0885-3185</s0>
</fA01>
<fA03 i2="1">
<s0>Mov. disord.</s0>
</fA03>
<fA05>
<s2>11</s2>
</fA05>
<fA06>
<s2>4</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Botulinum toxin is unsatisfactory therapy for fibromyalgia</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>PAULSON (G. W.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>GILL (W.)</s1>
</fA11>
<fA14 i1="01">
<s1>Department of Neurology, Ohio State University</s1>
<s2>Columbus, Ohio</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</fA14>
<fA20>
<s2>p. 459</s2>
</fA20>
<fA21>
<s1>1996</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>20953</s2>
<s5>354000060104000230</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 1996 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>2 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>96-0334229</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Movement disorders</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC02 i1="01" i2="X">
<s0>002B02B11</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Fibromyalgie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Fibromyalgia</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Fibromialgia</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Toxine</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Toxin</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Toxina</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Botulisme</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Botulism</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Botulismo</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Chimiothérapie</s0>
<s5>06</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Chemotherapy</s0>
<s5>06</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Quimioterapia</s0>
<s5>06</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Efficacité traitement</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Treatment efficiency</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Eficacia tratamiento</s0>
<s5>07</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Traitement</s0>
<s5>17</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Treatment</s0>
<s5>17</s5>
</fC03>
<fC03 i1="06" i2="X" l="GER">
<s0>Aufbereiten</s0>
<s5>17</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Tratamiento</s0>
<s5>17</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Homme</s0>
<s5>20</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Human</s0>
<s5>20</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Hombre</s0>
<s5>20</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Douleur</s0>
<s5>25</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Pain</s0>
<s5>25</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Dolor</s0>
<s5>25</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Bactériose</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Bacteriosis</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Bacteriosis</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Infection</s0>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Infection</s0>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Infección</s0>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Système ostéoarticulaire pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Diseases of the osteoarticular system</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Sistema osteoarticular patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Muscle strié pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Striated muscle disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Músculo estriado patología</s0>
<s5>38</s5>
</fC07>
<fN21>
<s1>232</s1>
</fN21>
</pA>
</standard>
<server>
<NO>PASCAL 96-0334229 INIST</NO>
<ET>Botulinum toxin is unsatisfactory therapy for fibromyalgia</ET>
<AU>PAULSON (G. W.); GILL (W.)</AU>
<AF>Department of Neurology, Ohio State University/Columbus, Ohio/Etats-Unis (1 aut., 2 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 1996; Vol. 11; No. 4; p. 459; Bibl. 2 ref.</SO>
<LA>Anglais</LA>
<CC>002B02B11</CC>
<FD>Fibromyalgie; Toxine; Botulisme; Chimiothérapie; Efficacité traitement; Traitement; Homme; Douleur</FD>
<FG>Bactériose; Infection; Système ostéoarticulaire pathologie; Muscle strié pathologie</FG>
<ED>Fibromyalgia; Toxin; Botulism; Chemotherapy; Treatment efficiency; Treatment; Human; Pain</ED>
<EG>Bacteriosis; Infection; Diseases of the osteoarticular system; Striated muscle disease</EG>
<GD>Aufbereiten</GD>
<SD>Fibromialgia; Toxina; Botulismo; Quimioterapia; Eficacia tratamiento; Tratamiento; Hombre; Dolor</SD>
<LO>INIST-20953.354000060104000230</LO>
<ID>96-0334229</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003378 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 003378 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:96-0334229
   |texte=   Botulinum toxin is unsatisfactory therapy for fibromyalgia
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024